Condition
Corneal Endothelial Cell Dysfunction
Total Trials
2
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
Treatment Research
2 treatments under study, led by Hcec Graft
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Phase 1 (2)
Trial Status
Recruiting1
Active Not Recruiting1
Clinical Trials (2)
Showing 2 of 2 trials
NCT07874503Phase 1RecruitingPrimary
Safety and Efficacy of Cultivated Allogeneic Corneal Endothelial Cells Attached to a Hydrogel Substrate (Endo-Tek™) as a Treatment for Corneal Endothelial Cell Dysfunction
NCT06726174Phase 1Active Not RecruitingPrimary
Cell Therapy for Corneal Endothelial Cell Dysfunction
Showing all 2 trials
Research Network
Common Treatments
- Hcec Graft1
- Eccec1
Active Sponsors
- National Taiwan University Hospital1
- Clinica Quesada1
- OcuCell1
Related Conditions
- Corneal Endothelial Cell1